SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biogen
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1686 75 0 BIIB
Emcee:  Harold Engstrom Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
586 William: I follow the CCR5 story as closely as I can, but have no contacts at scaram(o)uche-1/26/1998
585 off topic: Does anybody know anything about about Progenics? It is recommendedWilliam Nelson-1/25/1998
584 Let me add my thanks...this is a great initiative. Only other company I know oTom DuBois-1/23/1998
583 Speaking of big boys, a short report on Biogen is available at the Lehman BrothPseudo Biologist-1/23/1998
582 Anabelle, Thanks for posting the transcript, its nice to see a company that caWowzer-1/23/1998
581 Anabelle, As a lurker and shareholder, I also wanted to thank you. I certainly DubM-1/23/1998
580 Anabelle, thanks, this is great policy. PBPseudo Biologist-1/23/1998
579 4Q Earnings conference call - part 2 DOUG LIND: Thank you, Jim. If I can havBiogen Investor Relations-1/23/1998
578 Hi- My name is Annabelle Blake, I work in the IR department at Biogen. I have bBiogen Investor Relations-1/23/1998
577 Scott, thanks, this is much easier than Eddy's 10-point program. I think tPseudo Biologist-1/22/1998
576 Thanks, Harold. That is a great link that I haven't seen before, and will Scott-1/22/1998
575recap.com My dad sent me this excellent link. In case everyone doesn't alrHarold Engstrom-1/22/1998
574 PB, I just looked around on the web for posted policies on reimbursement by HMOScott-1/22/1998
573 Please fill us in when you get an answer. Note: the Stryker safety data would Scott-1/22/1998
572 From Eric Heckt's Jan 20 update regarding the pipeline: ---------- ProductVector1-1/22/1998
571 Scott, while it is certainly possible that OP-1 is no longer in the clinic, I pHarold Engstrom-1/22/1998
570 Sure. A lot can change in two months. Remember, in evaluating a drug you have Scott-1/22/1998
569 Scott, thanks for the visit. I still have to digest all this, but a quick takePseudo Biologist-1/22/1998
568 Do you think there can have been a change since the below was issued two monthsHarold Engstrom-1/22/1998
567 Note that OP-1 is not being mentioned any more as a drug in clinical developmenScott-1/22/1998
566 PB, thanks for the invite on the Idec thread to jump in on this one. Funny thiScott-1/22/1998
565 V1, Jim, thanks for the discussion on off-label use and the role of insurance oPseudo Biologist-1/22/1998
564 Jim, Sorry I was not clear. By off label I meant use of Avonex at earlier staVector1-1/22/1998
563 Off label implies use of the drug for other diseases. As of now none others arjim black-1/21/1998
562 Jim, What do you think is the likelihood of off label Avonex use for MS patientVector1-1/21/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News